ACLX's logo.
Ticker Symbol: ACLX

Arcellx Inc

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001786205

Company Profile

Arcellx Inc. is a clinical-stage biotechnology company. The Company is focused developing controllable cell therapies for the treatment of patients with cancer and other incurable diseases.

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: 25 West Watkins Mill Road
CEO: Rami Elghandour
Tags: N/A


Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $33.33
Change: $0.98 ( 3.03%)
Days Range: $31.60 - $33.79
Beta: 0.68
52wk. High: $48.92
52wk. Low: $17.87
Ytd. Change 10.61%
50 Day Moving Average: $34.77
200 Day Moving Average: $36.25
Shares Outstanding: 48358981


Market Cap: 161.2B
PE Ratio: -
EPS (TTM): 0


Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A